Overexpression of HSPB6 inhibits osteosarcoma progress through the ERK signaling pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Overexpression of HSPB6 inhibits osteosarcoma progress through the ERK signaling pathway ; volume:23 ; number:8 ; day:20 ; month:10 ; year:2023 ; pages:5389-5398 ; date:12.2023
Clinical and experimental medicine ; 23, Heft 8 (20.10.2023), 5389-5398, 12.2023
- Urheber
-
Guo, Liangyu
Xiao, Kangwen
Xie, Yuanlong
Yang, Zhiqiang
Lei, Jun
Cai, Lin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-023-01216-9
- URN
-
urn:nbn:de:101:1-2024030121033006223635
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Liangyu
- Xiao, Kangwen
- Xie, Yuanlong
- Yang, Zhiqiang
- Lei, Jun
- Cai, Lin
- SpringerLink (Online service)
Ähnliche Objekte (12)
LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8
Risedronate inhibits human osteosarcoma cell invasion
TIPE2 inhibits melanoma progression through MEK/ERK signaling
Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
CD97 inhibits osteoclast differentiation via Rap1a/ERK pathway under compression
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8
Risedronate inhibits human osteosarcoma cell invasion
TIPE2 inhibits melanoma progression through MEK/ERK signaling
Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
CD97 inhibits osteoclast differentiation via Rap1a/ERK pathway under compression
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8
Risedronate inhibits human osteosarcoma cell invasion
TIPE2 inhibits melanoma progression through MEK/ERK signaling
Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
CD97 inhibits osteoclast differentiation via Rap1a/ERK pathway under compression
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma